GEN Exclusives

More »

GEN News Highlights

More »
Nov 30, 2006

Angel to Manufacture Materials for CellCure Phase II Trials

  • Angel Biotechnology Holdings signed a development and GMP manufacturing deal with CellCure. Angel will manufacture and supply GMP materials for use in a T-cell based immuno-therapy as part of a Phase II trial to evaluate the treatment in patients with metastatic malignant melanoma.

    "Having worked only with laboratory-grown T cells in the past, the development of a final and fully GMP compliant bio-pharmaceutical preparation is crucial to our future success,” points out Anders Trojel, CEO of CellCure.

    The GMP production scale-up project, to be conducted at Angel's facilities, will last for 18 months.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?